Delivery Order SPE2DB20D3101-SPE2DB25FRRV3
- Not listed
- The Defense Logistics Agency awarded a $10,114.72 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) on September 15, 2025, with a completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $2,411.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion in 60-unit quantities, with performance in Conshohocken, Pennsylvania and completion targeted for September 24, 2025. This non-set-aside contract represents a competitive award under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) with a ceiling value of $2,072.32. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,307.00 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (60 single-use containers) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's larger prime contract vehicle. The pharmaceutical will be delivered to the company's distribution facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $20,448.66 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,216.72 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packaging. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, utilizing no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The...
- The Defense Logistics Agency awarded a $23,086.01 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 60-unit quantities. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,327.31 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the company's broader federal medical...
- The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded a $1,045.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% eye emulsion (30-count units), with an ultimate completion date of June 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRV3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $2,150.39 for Cyclosporine 0.05% Eye Emulsion (30 count) with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with the Defense Logistics Agency, which enables the company to supply a wide range of pharmaceutical products, medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical contracts with the DLA and serves critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government health systems. The Cyclosporine order supports the agency's broad medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/4/25 |